Celldex bolsters oncology pipeline with Curagen takeover
02 June 2009
Christopher Spillane
Please Login to read the full article.
02 June 2009
Christopher Spillane
Celldex Therapeutics has agreed to buy Curagen for $94.5 million in a deal that significantly strengthens its oncology portfolio and balance sheet.
The stock-for-stock transaction will add 11 human antibodies to Celldex's precision targeted immunotherapy platform and will extend...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Celldex raising over $30M to advance brain cancer vaccine returned by Pfizer
- US Krystexxa launch in motion, as Savient touts gout drug for "an unmet medical need", but concedes ramp-up may be slow
- PPD at centre of takeover speculation
- ImmunoGen banks $20M up front in Lilly antibody-drug conjugate deal
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
